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Letter to the Editor: COVID-19 Infections Do Not Change
with Increasing Altitudes from 1,000 to 4,700 m
Jesus M. Castagnetto,1 Jose Segovia-Juarez,2 and Gustavo F. Gonzales3
Dear Editor,
Coronavirus disease (COVID-19) infection, after thefirst case reported in Wuhan, China, on December 31,
2019 and declared a pandemic by the World Health Orga-
nization in March 2020, has climbed by September 2nd to
26,076,572 cases and 864,162 deaths worldwide.
Although it has been suggested that living at high alti-
tude could decrease the rate of coronavirus transmission and
mortality from COVID-19 (Arias-Reyes et al., 2020), new
studies have not confirmed this protective effect. In fact,
the case–fatality rate in Peru did not change with altitude
(Segovia-Juarez et al., 2020).
In the United States and Mexico, populations located
>2,000 m have a higher total cumulative number of COVID-
19 cases and a higher mortality rate attributable to COVID-19
than those located <1,500 m (Woolcott and Bergman, 2020).
This study included data up to April 13, 2020, in the United
States and up to May 13, 2020, in Mexico.
A recent comprehensive review calls into question whether
environmental factors, particularly ambient hypoxia, may be
responsible at high altitude for reducing viral transmission
and mortality due to COVID-19 (Pun et al., 2020). These
conflicting results need further clarification and more current
data. For this, we have assessed data from Peru, a country
with one of the highest per capita number of infections and
mortality rate worldwide.
We used data of COVID-19 cases from 1,636 districts
located from 5 to 4,705 m. The data set of COVID-19 cases
(N = 535,946, from March 6 to August 15, 2020) was ob-
tained from the National Open Data Platform (MINSA,
2020). Population and altitude data were gathered from Na-
tional Institute of Information and Statistics (INEI, 2019),
and combined with the aforementioned data set. This af-
forded altitude and district population information for
509,521 positive cases, representing people living at different
altitudes, and providing the possibility of studying the effect
of altitude with enough power to determine statistical sig-
nificance.
We considered three ranges: (1) altitudes <1,000 m, (2)
altitudes between 1,000 and 2,500 m, and (3) altitudes
‡2,500 m, and modeled the relationship between cases per
capita with respect to the district’s altitude in each group.
In the lower range (Fig. 1A), a significant inverse rela-
tionship is observed in line with a previous study in which
a coarser granularity level was used (Segovia-Juarez et al.,
2020). By contrast, in the medium- and high-altitude ran-
ges, the observed association of altitude and cases for
COVID-19 was not maintained. Whereas the data from
altitudes <1,000 m demonstrate an inverse relationship
(R2 = 0.0362; p < 0.001), and for data from 1,000 to
2,500 m (Fig. 1B, R2 = 0.0016; p = 0.537), and for altitudes
> 2,500 m (Fig. 1C, R2 = 0.0027; p = 0.120), this associa-
tion disappeared. It should be noted that very low R2 value
for the data < 1,000 m demonstrates that altitude can only
explain *3% of the totality variability. In addition, the
fact that higher altitudes are not associated with increased
infection and mortality suggests that the positive associa-
tion found over a very low altitude range may be a false
positive finding.
These results suggest that factors associated with in-
creasing altitude such as ultraviolet B radiation, hypoxia, low
temperature, aridity, and high hemoglobin levels might not
afford protection against COVID-19 infection. The observed
change in infection rates at low altitudes might be associated
with factors such as high population density, large popula-
tions, and perhaps exposure to greater air pollution, such as
PM2.5 particulates (Pun et al., 2020; Vásquez-Apestegui
et al., 2020).
Believing that altitude might protect against COVID-19
infection and mortality might lead people to become over-
confident and engage in behaviors that could reduce the
effectiveness of protective measures such as physical dis-
tancing, washing hands, mask wearing, and avoiding large
gatherings of people.
In conclusion, our data demonstrate that high altitude does
not protect against COVID-19 infection and mortality.
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FIG. 1. Association between per capita COVID-19 cases (at the district level) in Peru in relation to altitude (meters).
(A) Altitudes <1,000 m. (B) Altitudes from 1,000 to <2,500 m. (C) Altitudes from 2,500 m to higher. Each figure includes
coefficient of variation (R2), p-value, number of districts, and number of COVID-19 cases. Source: MINSA (2020).
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